Preclinical rationale and phase I clinical trial of the adriamycin analog, AD 32.
Blum RH, Garnick MB, Israel M, Panellos GP, Henderson IC, Frei E. Preclinical rationale and phase I clinical trial of the adriamycin analog, AD 32. Recent Results Cancer Res. 1981; 76:7-15.